Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage
Current Opinion in Toxicology · 2026-12 · 48 · 100625
DOI: 10.1016/j.cotox.2026.100625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Opinion in Toxicology, 2026-12. Verfasst von Yvonne Will und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Will, Y., Talecki, L., & Roberts, R. (2026). Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage. Current Opinion in Toxicology, 48, 100625. https://doi.org/10.1016/j.cotox.2026.100625
Vancouver
Will Y, Talecki L, Roberts R. Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage. Current Opinion in Toxicology. 2026;48:100625. doi:10.1016/j.cotox.2026.100625
BibTeX
@article{Will2026,
author = {Will, Yvonne and Talecki, Lindsey and Roberts, Ruth},
title = {Decision-focused discovery toxicology: Why early, human-relevant risk assessment of new drugs gives a competitive advantage},
journal = {Current Opinion in Toxicology},
year = {2026},
volume = {48},
pages = {100625},
doi = {10.1016/j.cotox.2026.100625}
}
EUVIMED